Skip to main content

Our website uses cookies to give you the most optimal experience online by: measuring our audience, understanding how our webpages are viewed and improving consequently the way our website works, providing you with relevant and personalized marketing content.
You have full control over what you want to activate. You can accept the cookies by clicking on the “Accept all cookies” button or customize your choices by selecting the cookies you want to activate. You can also decline all non-necessary cookies by clicking on the “Decline all cookies” button. Please find more information on our use of cookies and how to withdraw at any time your consent on our privacy policy.

Managing your cookies

Our website uses cookies. You have full control over what you want to activate. You can accept the cookies by clicking on the “Accept all cookies” button or customize your choices by selecting the cookies you want to activate. You can also decline all non-necessary cookies by clicking on the “Decline all cookies” button.

Necessary cookies

These are essential for the user navigation and allow to give access to certain functionalities such as secured zones accesses. Without these cookies, it won’t be possible to provide the service.
Matomo on premise

Marketing cookies

These cookies are used to deliver advertisements more relevant for you, limit the number of times you see an advertisement; help measure the effectiveness of the advertising campaign; and understand people’s behavior after they view an advertisement.
Adobe Privacy policy | Marketo Privacy Policy | Pardot Privacy Policy | Oktopost Privacy Policy | MRP Privacy Policy | AccountInsight Privacy Policy | Triblio Privacy Policy

Social media cookies

These cookies are used to measure the effectiveness of social media campaigns.
LinkedIn Policy

Our website uses cookies to give you the most optimal experience online by: measuring our audience, understanding how our webpages are viewed and improving consequently the way our website works, providing you with relevant and personalized marketing content. You can also decline all non-necessary cookies by clicking on the “Decline all cookies” button. Please find more information on our use of cookies and how to withdraw at any time your consent on our privacy policy.

The Center for Genomics and Oncological Research (GENyO)

GENyO expands analytic capacity for precision medicine

At a glance

GENyO expands analytic capacity to accelerate strategically important research that can help pharma companies create new treatments and support the Andalusian Department of Health’s drive to bring precision medicine to the region’s 9 million citizens.

Outcomes

Researchers enjoy increased performance, scalability, and reliability. They have the flexibility to run diverse projects, including many that involve sophisticated analysis of heterogeneous data sets.

This finer-grained diagnostic capability can help pharma companies choose the best treatments for each patient and develop new treatments, and it is particularly valuable for people suffering from less common difficult-to-diagnose autoimmune diseases. The progress in this area is tremendously exciting.

Marta Alarcón Riquelme,

Scientific Director Genomic Unit and Medical Genomics Department, GENyO

A growing need for advanced analytics

A multidisciplinary research institute focused on the genetic basis of human diseases, GENyO needs scalable, high-performance computing resources to turn clinical and genomic data into scientific insights that ultimately improve human health. Its small cluster and individual workstations were swamped by growing demand.

Atos solution

GENyO deployed an Atos BullSequana X blade system, with each node powered by Intel® Xeon® processor. The system provides over 11 teraflops of computing power and 2.25 terabytes of RAM.

The solution has been deployed under the umbrella of the Atos HPC, AI and Quantum Life Sciences Center of Excellence (LSCoE), the realization of Atos global strategy to bring advanced computing technologies closer to life sciences projects with the goal of discovering fresh, innovative solutions.

Download the client story

Outcomes

  • Researchers enjoy increased performance, scalability, and reliability. They have the flexibility to run diverse projects, including many that involve sophisticated analysis of heterogeneous data sets.
  • GENyO accelerates strategically important research that can help pharma companies create new treatments and support the Andalusian Department of Health’s drive to bring precision medicine to the region’s 9 million citizens.
  • With compact, energy-efficient technologies from Intel and Atos, GENyO reduces power consumption and frees floor and rack space, supporting future growth requirements.
  • Solution delivered through the Atos Life Sciences Center of Excellence (LSCoE) that provides access to experts in advanced computing technologies.

Our Experts

Natalia Jiménez Lozano

Head of Atos Life Science Center of Excellence

Follow or contact Natalia:

Related resources

Blog

Technological advances to prevent skin cancer

Skin cancer accounts for one in every three cancers diagnosed. Fortunately, technological advances are helping to fight the disease.

Thought leadership

Journey 2024 in healthcare and life sciences

Healthcare organizations face complex challenges to meet the demands of growing and aging populations, together with rises in long-term health conditions and the needs of the pandemic response.

Client story

CNAG- Sequencing and Supercomputers

From Data to Discoveries, Atos helps to drive new health insights faster.

On-demand webinar

Leap your life sciences project to the “quantum” level

Atos quantum experts will walk you through some obvious life sciences quantum use cases and inspire you to think of other relevant applications.

Research

Bringing to life unimaginable

Quantum, high performance computing (HPC) as well as edge computing assisted by artificial intelligence hold exciting, transformative potential for the life sciences sector.

Solutions

HPC, AI & Quantum Life Sciences Center of Excellence

New technologies such as high-performance computing (HPC), quantum computing (QC) and artificial intelligence (AI) have the potential to bring about game changing results in genomics and biodata.

More client stories

Upgrading to SAP S/4HANA stimulates business growth

Digitally transforming healthcare for Western Australia

Scottish Water wastewater network management

Driving performance with Cloud

Interested in our solutions?